The Cost Effectiveness of the Trial

In about six weeks, we will finish a three-year follow-up. We don't have any extrapolation trajectories outside the 12-month period. The way it's done is they just take everything and say, on balance, any differences you see should be related to the trial. Just out of interest, okay, sorry. Is that cost effectiveness? Is that within the trial duration? Are there any estimates based on typical trajectories of what that person's sort of health needs are at any given timeframe beyond the trial?"